To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
ChemNavigator's Compound Offerings Surpass 2.3 Million Compounds With the Addition of CambridgeSoft's ChemACX Reagent Database
12-18-2001: ChemNavigator, a cheminformatics company, announced today that its iResearch? System will incorporate CambridgeSoft's ChemACX database of nearly 200,000 reagents, significantly increasing the range of chemistry available to drug discovery researchers.
ChemNavigator's iResearch? System is a proprietary search and comparison system that allows users to create a chemistry space, based on business and chemistry rules, that is specific to a project. The iResearch System provides researchers with the ability to populate the project chemistry space with compounds and related scientific data, specific to a particular project, which is automatically updated as the data landscape changes with the life of the project.
Providing access to reagents from the ChemACX database in addition to the iResearch System Library's 2.2 million drug-like compounds represents the latest evolution of ChemNavigator's growing suite of products and services. With the fastest search technology in the industry, the iResearch System allows clients to quickly search the newly included reagents and offers the flexibility to view the details of multiple search results, sorted and grouped in various ways, using relevant criteria. The System also adds valuable links to external scientific data such as patents, toxicology results, government studies, ligand binding data, and known drugs related to the reagents.
"Offering the ChemACX database coupled with our iResearch System Library provides our clients with the ability to not only access drug-like compounds, but also gives them access to building blocks from some of the industry's most respected suppliers," said Scott Hutton, president and CEO of ChemNavigator. "Offering the ChemACX to our clients enhances our ability to provide the most comprehensive, up-to-date view on available chemistry."
"Our agreement with ChemNavigator makes the ChemACX part of a powerful tool for drug discovery and one that will be increasingly important for researchers," said Dr. Richard Morris, president, e-commerce of CambridgeSoft.com. "ChemNavigator's growing business relationships with companies involved in drug discovery puts our database of reagents in the hands of scientists who will use them to develop treatments for diseases."
When a client licenses the iResearch System Library or joins as a member of the iResearch System they have the option of licensing the ChemACX database, as a partner catalog, for an additional annual fee. Clients will have the choice of ordering the reagents through ChemNavigator's compound procurement service or directly from the supplier.
The ChemACX database is a comprehensive source of available reagents. CambridgeSoft has compiled an on-line catalog containing the most up to date product information from over 200 of the top chemical suppliers such as Aldrich, Fisher, ACROS, Lancaster, Maybridge and others serving the research community. All data available in each catalog is faithfully reproduced, including detailed chemical structures and materials safety information.
Watchlist
This is where you can add this news to your personal favourites
- 1Arkema speeds up its development in Asia and in green chemistry with the closing of the acquisition of Hipro Polymers and Casda Biomaterials
- 2BASF increases prices for ethanolamines in Europe
- 3LANXESS expands Jhagadia site to serve booming Indian market
- 4Bayer CO2 project among best ideas for the future
- 5Rhodia and Avantium to jointly develop biobased polyamides
- 6From seaweed to biofuels
- 7Bayer rated the most sustainable German company in its sector
- 8How seawater could corrode nuclear fuel
- 9Largest and most efficient BOPP line for Africa
- 10DEKRA: Change in management of Business Unit Industrial
- 1Baytron P®– Gateway to a new generation of polymers
- 2Rhodia and Avantium to jointly develop biobased polyamides
- 3Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5AkzoNobel selects Tebodin for the conversion of the chlorine plant in Frankfurt
- 6AkzoNobel doubles dimethylether production
- 7Are you certain, Mr. Heisenberg?
- 8BASF invests $50 million to acquire equity ownership position in Sion Power
- 9Bayer MaterialScience commissions new hydrogenation technical center
- 10Illinois Tool Works Inc. acquires AppliChem GmbH
- 1Evonik Industries’ Coatings & Additives announces price increases
- 2Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 3Baytron P®– Gateway to a new generation of polymers
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5Drew Industrial Division of Ashland Specialty Chemical Company purchases industrial water-treatment business of London-based Fer
- 6Electrochemical extraction of silicon: new approach for a more environmentally friendly large-scale process?
- 7LG-DOW Polycarbonate Plant Starts Production in Korea to Effectively Meet Regional Needs
- 8Caflon® surfactants from Univar as substitutes for banned nonylphenol ethoxylates
- 9Largest and most efficient BOPP line for Africa
- 10New Fluka and Riedel-de Haën Catalog Features Over 1,500 New Products
- Photonics Innovation Award for WITec
- Atomic Layer Deposition (ALD) to enable novel, high efficiency silicon nanor ...
- Borealis Schwechat celebrates 50 years of polypropylene production
- Movento Wins Agrow Award for Most Innovative Chemistry
- Boeing’s 787 Dreamliner Uses Agilent Technologies’ Handheld Spectrometer to ...
- ABB divests air handling business for US$ 225 million -
- QIAGEN Genomics Enters Into Tuberculosis SNP Genotyping Research And License Agreement with TIGR and MMC - - Groups Collaborate to Analyze Genetic Variation in Different Strains of M. Tuberculosis
- Nutrinova and Ceapro Inc. announce an exclusive world-wide distribution agreement -
- Genmab Initiates Second Phase II Study With HuMax-CD4 -
- European_Federation_of_Pharmaceutical_Industries_and_Associations
